Skip to main content
Membership NewsMembership News Archive

Doris-Ann features on a The King’s Fund event panel and attends NAM meetings in Brussels

By December 2, 2022No Comments

The King’s Fund held a conference ‘Meeting Demand: the changing picture of diagnostics’ on 16 November.

There was a breakfast session before the official opening plenary focussed on Antimicrobial Resistance which was timely as it was just in advance of World Antimicrobial Resistance Awareness Week. The panel discussed how access to diagnostics in primary care needs to be improved as this is where most of decisions about prescribing antibiotics are taken and could make the biggest impact on AMR in healthcare in the UK. Ended with a call to action for system-wide thought on how to make changes.

The plenary session had 3 great speakers giving their Vision of Diagnostics and Mike Richards opened with an overview of the community diagnostics centres and how these could develop with better access for patients to diagnostics both directly and indirectly. There were several streams of discussion during the meeting looking at different aspects including (lack of) workforce – one of those meetings like a great menu in a restaurant where it’s hard to choose the option to attend!

The day ended with a panel session including Doris-Ann, discussing views on how adoption for tests could be improved and the routes, such as the Accelerated Access Collaborative which were looking at doing this.

The opening plenary session with Prof Sir Mike Richards speaking as well as Prof Carole Longson and Dr Kath Halliday (President, Royal College of Radiologists)


This week Doris-Ann spent a couple of days in Brussels at MedTech Europe where she attended meetings on the market audit programmes together with John Bagshaw. These had a real focus on the quality of the information and how additional participation would improve this further.

Doris-Ann was pleased to see that of the 13 countries in Europe who participate in the scheme, the UK has the same number of participants as France with 27 companies and only Germany have more with 35. All BIVDA members with UK sales are eligible to join so please ask if you would like to learn more about the information the market audit survey provides to participating companies.

There was a retirement dinner on Wednesday evening to mark the contribution of Jean-Noel Bouillon who has been the IVD membership ‘champion’ at MTE.  The IVD NAM meeting looked at issues with the IVDR and how MTE will be communicating these and also at the communication campaign for the use of diagnostics in cancer through their VODI (Value Of Diagnostic Information) activities.

Yesterday there was a joint NAM session with Medical Devices looking at issues coming through the EU that could affect both sectors such as the product Liability Directive and the AI Liability Directive.

MedTech Europe NAM meeting – the chair for National Associations is Carlos Sisternas (2nd from right) of Fenin in Spain.

Ben Kemp